The Human Genome Project: How Private Sector Developments Affect the Government Program [Hearing Charter; Statement of Dr. Ari Patrinos, Associate Director, Office of Biological and Environmental Research, Office of Energy Research, Department of Energy; Statement of Dr. J. Craig Venter, President and Director, The Institute for Genomic Research; Statement of Dr. Francis S. Collins, Director, National Human Genome Research Institute; Statement of Dr. David J. Galas, President and Chief Scientific Officer, Chiroscience R & D Inc.; Testimony of Dr. Maynard V. Olson]
United States. Congress. House. Committee on Science. Subcommittee on Energy and Environment
Unpublished documents. Testimony before the Subcommittee 1998 June 17; [multiple pages]
Showing items related by title, author, creator and subject.
Stem Cell Research: Patenting and Health Implications: Testimony of Maria C. Freire, Ph.D., Director, National Institutes of Health Office of Technology Transfer [Hearing of the Subcommittee on Labor, Health and Human Service, and Education, Committee on Appropriations, U.S. Senate. 26 January 1999] Freire, Maria C. (1999-02)